Results
1 -
10 of
24Raloxifene HCl: A Tissue Selective Estrogen Receptor Modifier (SERM) for Replacement Therapy in Postmenopausal Women, Womenu2019s Health and Menopause Novel cationic supersaturable nanomicellar systems of raloxifene hydrochloride with enhanced biopharmaceutical attributes, Drug Delivery and Translational Research Journal of Endocrinological Investigation.
Estradiol and raloxifene induce the proliferation of osteoblasts through G-protein-coupled receptor GPR30, Journal of Endocrinological Investigation Highlights, Journal of Endocrinological Investigation Treatment of Postmenopausal Women with Osteoporosis or Low Bone Density with Raloxifene, Osteoporosis International Geographic Differences in Bone Turnover: Data from a Multinational Study in Healthy Postmenopausal Women, Calcified Tissue International The effects of raloxifene on bone turnover markers and bone mineral density in women on maintenance hemodialysis, Clinical and Experimental Nephrology Effects of raloxifene on lipid and bone metabolism in postmenopausal women with type 2 diabetes, Journal of Bone and Mineral Metabolism